Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


27.07.2026

3 Abdom Radiol (NY)
1 ACS Omega
1 Am J Clin Oncol
1 Am J Clin Pathol
1 Analyst
1 Ann Intern Med
1 Arch Public Health
1 Autophagy
1 Biomed Pharmacother
4 BMC Cancer
1 BMC Prim Care
1 Cancer Causes Control
1 Cancer Cytopathol
1 Cancer Med
1 Cell Death Discov
1 Clin Infect Dis
1 Clin Obstet Gynecol
1 Clin Radiol
1 Cureus
1 DNA Cell Biol
1 EClinicalMedicine
1 Front Immunol
1 Front Oncol
3 Front Public Health
1 Funct Integr Genomics
1 Geburtshilfe Frauenheilkd
2 Int J Cancer
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Womens Health
1 J Cancer Educ
1 J Comp Eff Res
4 J Contemp Brachytherapy
1 J Glob Health
2 J Gynecol Oncol
1 J Low Genit Tract Dis
1 J Med Screen
2 J Obstet Gynaecol Res
1 J Pediatr Adolesc Gynecol
1 J Prim Care Community Health
1 J Racial Ethn Health Disparities
1 J Transl Med
1 J Virol Methods
1 Lasers Med Sci
1 Mol Biol Rep
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Naunyn Schmiedebergs Arch Pharmacol
1 Niger Med J
1 Oncol Lett
1 Oncol Rep
1 Pak J Pharm Sci
2 PLoS One
1 Psychol Res Behav Manag
1 Radiother Oncol
1 Rev Assoc Med Bras (1992)
1 Rev Esp Patol
1 Rev Esp Quimioter
1 Sci Rep
1 Spectrochim Acta A Mol Biomol Spectrosc
1 Urology
1 Womens Health (Lond)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. VIRARKAR M, Javadi S, Aziz A, Shah R, et al
    Quantitative imaging biomarkers as prognostic indicators in squamous cell cervical carcinoma: a retrospective cohort analysis.
    Abdom Radiol (NY). 2026;51:4082-4091.
    PubMed         Abstract available

  2. ZHANG M, Lu Y, Song J, Zhang A, et al
    Deep learning reconstruction versus conventional parallel imaging for sagittal T2-weighted MRI in cervical cancer: a comparison of acceleration factors.
    Abdom Radiol (NY). 2026 Jul 20. doi: 10.1007/s00261-026-05685.
    PubMed         Abstract available

  3. WINKELMANN MT, Bareiss A, Winkelmann JT, Hoffmann S, et al
    Abbreviated T2w-only pelvic MRI for local tumor staging of cervical cancer: a pragmatic approach for time-critical and resource-limited settings.
    Abdom Radiol (NY). 2026 Jul 20. doi: 10.1007/s00261-026-05691.
    PubMed         Abstract available


    ACS Omega

  4. KIRUBA B, Sundararajan V
    Synergistic Profiling of Programmed Cell Death and Immune Responses Identifies a Novel Prognostic Index for Cervical Cancer.
    ACS Omega. 2026;11:41577-41596.
    PubMed         Abstract available


    Am J Clin Oncol

  5. MUSHEER A, Mannan MS, Khan MW, Bhatti A, et al
    PD-1 Inhibition With Camrelizumab in Cervical Cancer: A Systematic Review and Meta-Analysis.
    Am J Clin Oncol. 2026 Jul 21. doi: 10.1097/COC.0000000000001352.
    PubMed         Abstract available


    Am J Clin Pathol

  6. WEATHERHEAD K, Nguyen C, Henry T, Harrington S, et al
    Enhancing efficiency and improving turnaround time: real-world impact of the Genius Digital Diagnostics System implementation.
    Am J Clin Pathol. 2026;166:aqag081.
    PubMed         Abstract available


    Analyst

  7. SINGH SK, Kumar P
    Synergistic U-bent geometry and bimetallic plasmonics for ultra-sensitive fibre-optic SPR biosensing of cervical cancer.
    Analyst. 2026 Jul 20. doi: 10.1039/d6an00563.
    PubMed         Abstract available


    Ann Intern Med

  8. CHEUNG LC, Mao F, Rydzak G, Wentzensen N, et al
    Benefits and Harms of Immediate Versus Delayed Treatment of Cervical Intraepithelial Neoplasia Grade 2 : A Target Trial Emulation.
    Ann Intern Med. 2026;179:980-987.
    PubMed         Abstract available


    Arch Public Health

  9. DEL VALLE D, Lamo EA, Exposito AD, Amorin AG, et al
    SPEACx: a screening pathway-based evaluation and audit framework of cervical cancer diagnostic routes in a population-based programme.
    Arch Public Health. 2026;84:166.
    PubMed         Abstract available


    Autophagy

  10. SUN X, Qian S, Ye G, Wang Q, et al
    The ubiquitination of CD274 at MERCs enhances the anti-tumor immunity of cervical cancer.
    Autophagy. 2026 Jul 23. doi: 10.1080/15548627.2026.2708579.
    PubMed         Abstract available


    Biomed Pharmacother

  11. YAMADA H, Yokoi A, Suzuki K, Yoshida K, et al
    Transcriptome profiling identifies RET activation as a therapeutic target in gastric-type endocervical adenocarcinoma.
    Biomed Pharmacother. 2026;201:119696.
    PubMed         Abstract available


    BMC Cancer

  12. JIAHAN L, Siqi L, Keliya M, Lili H, et al
    HPV genotype distribution and cervical lesions in colposcopy-referred women in Western China: a cross-sectional study.
    BMC Cancer. 2026 May 26. doi: 10.1186/s12885-026-16209.
    PubMed         Abstract available

  13. PAKDAMAN K, Shirvani AE, Pakdaman K, Nikbakht HA, et al
    Systematic review and meta-analysis of lung metastases incidence in cervical cancer patients.
    BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16579.
    PubMed         Abstract available

  14. ZHANG HH, Liu M, Chen YN, Zhang MR, et al
    Screening of shared molecular markers between cervical cancer and major depressive disorder and the mechanism of CRAT/CLIC4 regulating EMT in cervical cancer cells.
    BMC Cancer. 2026 Jul 20. doi: 10.1186/s12885-026-16571.
    PubMed         Abstract available

  15. TONG Z, Mao S, Tao H, Gan P, et al
    PAX1 methylation for triage of HR-HPV-positive women: a comparative analysis with cytology and HPV16/18 genotyping.
    BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16235.
    PubMed         Abstract available


    BMC Prim Care

  16. SHIN MB, Volpi CR, Szewczyk W, Hannon PA, et al
    Predictors of routine HPV-based cervical cancer screening adoption in federally qualified health centers within a multi-state practice research network 2012-2022: retrospective observational study.
    BMC Prim Care. 2026 Jul 21. doi: 10.1186/s12875-026-03452.
    PubMed         Abstract available


    Cancer Causes Control

  17. BOYD L, Nightingale C, Martinez-Gutierrez J, Machado Colling A, et al
    Access to cervical screening in Australian general practices: a cross-sectional study using a 'secret shopper' approach.
    Cancer Causes Control. 2026;37:129.
    PubMed         Abstract available


    Cancer Cytopathol

  18. YODA RA, Huang EC
    Implementation and impact of primary HPV testing in cervical cancer screening: Historical perspectives and institutional experience at a large academic medical center.
    Cancer Cytopathol. 2026;134:e70129.
    PubMed         Abstract available


    Cancer Med

  19. RATH N, Neis K, Holleczek B
    Analysis of Age, Period and Cohort Trends in Cervical In Situ and Invasive Carcinomas for Assessing the Utility of Screening Approaches-Results From the Saarland Cancer Registry.
    Cancer Med. 2026;15:e72127.
    PubMed         Abstract available


    Cell Death Discov

  20. LIAO D, Shi L, Cui Y, Li C, et al
    PIN1 enhances SUMOylation of YAP1 and inhibits ferroptosis via autophagy-dependent degradation of ACSL4 in cervical cancer.
    Cell Death Discov. 2026 Jul 22. doi: 10.1038/s41420-026-03257.
    PubMed         Abstract available


    Clin Infect Dis

  21. HELLNER K, Simon P, De Sutter P, Vahula KL, et al
    A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women w
    Clin Infect Dis. 2025 Dec 17:ciaf658. doi: 10.1093.
    PubMed         Abstract available


    Clin Obstet Gynecol

  22. BARBERA JP, Schwartz BI
    Preventive Gynecologic Care for Patients With Disabilities.
    Clin Obstet Gynecol. 2026;69:278-283.
    PubMed         Abstract available


    Clin Radiol

  23. ZHANG A, Lu Y, Song J, Zhai W, et al
    The value of dynamic contrast-enhanced magnetic resonance imaging (MRI) in predicting postoperative recurrence of early-stage cervical cancer.
    Clin Radiol. 2026;100:107422.
    PubMed         Abstract available


    Cureus

  24. MAJDI A, Harbaj S, Agdi B, Chakir R, et al
    Stereotactic Body Radiotherapy as a Salvage Treatment for Regional Lymph Node Recurrence of Cervical Cancer: Two Case Reports With Complete Metabolic Response and Literature Review.
    Cureus. 2026;18:e111361.
    PubMed         Abstract available


    DNA Cell Biol

  25. LI Z, Zhao J, Hao L, Wang J, et al
    Siglec-15 Enhances Cisplatin Resistance in Cervical Cancer Cells by Promoting Mitochondrial Retrograde Signaling Through Activation of the MAPK Pathway.
    DNA Cell Biol. 2026 Jul 23:10445498261470989. doi: 10.1177/10445498261470989.
    PubMed         Abstract available


    EClinicalMedicine

  26. LAHOLE BK, Tanga AT, Abdi FH, Mekuria SF, et al
    Challenges of scaling up cervical cancer screening in Ethiopia: a qualitative socio-ecological study.
    EClinicalMedicine. 2026;97:104057.
    PubMed         Abstract available


    Front Immunol

  27. PAN L, Zhang P, Zhang D, Wang G, et al
    Mitochondrial reprogramming in cervical cancer: crosstalk with tumor immunity, HPV oncogenic signaling, and therapeutic resistance.
    Front Immunol. 2026;17:1884498.
    PubMed         Abstract available


    Front Oncol

  28. KARNIK M, Anantharaju PG, Sharma A, Sukocheva O, et al
    Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives.
    Front Oncol. 2026;16:1857128.
    PubMed         Abstract available


    Front Public Health

  29. AL-OMAIR OM, Alabdullatif NS
    Health-related social media engagement and cervical cancer prevention: associations with HPV knowledge, vaccine awareness, and pap smear utilization among US women.
    Front Public Health. 2026;14:1782691.
    PubMed         Abstract available

  30. WANG H, Zhao S, Lin H, Zhao S, et al
    Factors influencing HPV vaccination intention and uptake behaviors among medical students based on the health belief model and vaccine hesitancy theory: a cross-sectional study.
    Front Public Health. 2026;14:1894458.
    PubMed         Abstract available

  31. LI L, Xu X, Jiang P, Wang FL, et al
    Policy events, emotional fluctuations, and vaccination behavior: a longitudinal analysis of public opinion on HPV vaccines in China.
    Front Public Health. 2026;14:1889894.
    PubMed         Abstract available


    Funct Integr Genomics

  32. CHEN Y, Hong Y, Wei D, Fan L, et al
    Integrative multi-omics analysis identifies FAM3D as a prognostic tumor suppressor in cervical cancer.
    Funct Integr Genomics. 2026;26:198.
    PubMed         Abstract available


    Geburtshilfe Frauenheilkd

  33. HENES M, Mann E, Hirchenhain C, Kentner A, et al
    Correction: Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Persistent HPV Infections and Squamous Cell Lesions: Evaluation of over 10000 Patients.
    Geburtshilfe Frauenheilkd. 2026;86:e2.
    PubMed         Abstract available


    Int J Cancer

  34. BONDE J, Schroll JB, Pedersen BT, Lynge E, et al
    Health Care Policy Implementation Trial of Primary Human Papillomavirus-Based Cervical Screening in Denmark.
    Int J Cancer. 2026;159:1464-1476.
    PubMed         Abstract available

  35. PELLEGRINO RA, Shepherd BE, Pujari S, Fink V, et al
    Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium.
    Int J Cancer. 2026 Apr 16. doi: 10.1002/ijc.70503.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  36. MCCLOSKEY G, Ruck C, Booth A, Mutamba B, et al
    Evaluating the feasibility of using SMS to recruit women for cervical cancer screening in Rwanda: A pilot study.
    Int J Gynaecol Obstet. 2026 Jul 21. doi: 10.1002/ijgo.71225.
    PubMed         Abstract available


    Int J Gynecol Cancer

  37. SRAJER A, Hutchinson JM, Metcalfe A, Brenner DR, et al
    Cervical cancer screening among transgender and gender diverse individuals: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2026;36:104850.
    PubMed         Abstract available


    Int J Womens Health

  38. GAO S, Wang K, Su X, Wu Y, et al
    Limited Survival Benefit of Preoperative Conization Before Radical Surgery in Stage IB Cervical Cancer: An IPTW-Adjusted Retrospective Cohort Study.
    Int J Womens Health. 2026;18:612277.
    PubMed         Abstract available


    J Cancer Educ

  39. HE H, Cai H
    Reply to Peikai Sun's Comment on "Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok".
    J Cancer Educ. 2026 Jul 23. doi: 10.1007/s13187-026-02947.
    PubMed        


    J Comp Eff Res

  40. LEE AY, Lee SH, Kim MJ, An JE, et al
    Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients.
    J Comp Eff Res. 2026 Jul 24:e250194. doi: 10.57264/cer-2025-0194.
    PubMed         Abstract available


    J Contemp Brachytherapy

  41. LIU C, Wang X, Zhang N, Li J, et al
    Can image-guided external beam radiotherapy boost be an alternative when intracavitary brachytherapy is unavailable for locally advanced cervical cancer? A dosimetric analysis and literature review.
    J Contemp Brachytherapy. 2026;18:171-178.
    PubMed         Abstract available

  42. HANDE V, Rossi L, Westerveld H, Luthart L, et al
    Automated planning in image-guided adaptive brachytherapy for cervical cancer: Impact analysis on patient workflows in high-volume centers.
    J Contemp Brachytherapy. 2026;18:163-170.
    PubMed         Abstract available

  43. PAVICAR B, Kukic D, Milosavljevic A, Sovilj BK, et al
    Automated EQD(2) reporting for cervical cancer high-dose-rate brachytherapy using a standalone ESAPI-based application.
    J Contemp Brachytherapy. 2026;18:196-203.
    PubMed         Abstract available

  44. CHIANG JS, Conteh AM, Niedermayr T, Kidd E, et al
    The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures.
    J Contemp Brachytherapy. 2026;18:142-146.
    PubMed         Abstract available


    J Glob Health

  45. PAN F, Greuter MJ, Koot JA, Cubie H, et al
    Efficient high-risk human papillomavirus screening through pooled testing: a simulation study based on real-world data in low- and middle-income countries.
    J Glob Health. 2026;16:04275.
    PubMed         Abstract available


    J Gynecol Oncol

  46. CHEN L, Chen T, Tu N, Dong L, et al
    Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial.
    J Gynecol Oncol. 2026 Jul 9. doi: 10.3802/jgo.2027.
    PubMed         Abstract available

  47. YOO H, Kim H, Hwang JH, Suh DH, et al
    Association between delayed confirmatory testing and cervical cancer detection among women with abnormal screening results.
    J Gynecol Oncol. 2026 Jul 7. doi: 10.3802/jgo.2027.
    PubMed         Abstract available


    J Low Genit Tract Dis

  48. SONGSIRITHAT P, Jareemit N, Warnnissorn M, Therasakvichya S, et al
    Investigating Discrepancies Between Original and Review Diagnoses in Cervical Cancer and Precancerous Lesions.
    J Low Genit Tract Dis. 2026 Jul 24. doi: 10.1097/LGT.0000000000000973.
    PubMed         Abstract available


    J Med Screen

  49. NATH A, Pant A, Thangavel G, Kunnumal A, et al
    A systematic review and meta-analysis of diagnostic accuracy of urine self-sampling for human papillomavirus detection in cervical cancer screening.
    J Med Screen. 2026 Jul 24:9691413261471634. doi: 10.1177/09691413261471634.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  50. FAN Y, Wang W, Sun Y, Guo S, et al
    The Expression and Clinical Value of miR-483-5p in Cervical Cancer and Its Regulation of Cervical Cancer via TIMP2.
    J Obstet Gynaecol Res. 2026;52:e70396.
    PubMed         Abstract available

  51. KANG OJ, Koh JH, Lee SW, Park JY, et al
    Neoadjuvant Paclitaxel-Carboplatin Chemotherapy Followed by Cesarean Radical Hysterectomy in Pregnant Patients With Cervical Cancer: Obstetric, Neonatal, and Surgical Outcomes.
    J Obstet Gynaecol Res. 2026;52:e70403.
    PubMed         Abstract available


    J Pediatr Adolesc Gynecol

  52. WANG Z, Zhan Y, Shi G, Ruan J, et al
    Vaginoscopic Resection of Cervical Botryoid Sarcoma in a Pediatric Patient.
    J Pediatr Adolesc Gynecol. 2026;39:551-552.
    PubMed         Abstract available


    J Prim Care Community Health

  53. EJAZ R, Chatzipanagiotou OP, Alizai Q, Sarfraz A, et al
    Patient Portal Use and Cancer Screening in the United States: Individual Associations and Population Impact.
    J Prim Care Community Health. 2026;17:21501319261471881.
    PubMed         Abstract available


    J Racial Ethn Health Disparities

  54. PHUNG MT, Inyangetuk RS, Onar GS, Nguyen B, et al
    Insights of Vietnamese American Women on Cervical Cancer Screening and HPV Self-Sampling.
    J Racial Ethn Health Disparities. 2026 Jul 20. doi: 10.1007/s40615-026-03114.
    PubMed         Abstract available


    J Transl Med

  55. CHEN X, Zhou D, Lin Y, Lin W, et al
    Cross-layer multiomic and digital pathology analysis identifies a malignant keratinization state linked to immune exclusion in cervical squamous carcinoma.
    J Transl Med. 2026;24:949.
    PubMed         Abstract available


    J Virol Methods

  56. SARGENT A, Rebolj M, Denton K, Mathews C, et al
    HPValidate - Technical optimisation of self-collected samples for HPV testing within the NHS England cervical screening programme.
    J Virol Methods. 2026;345:115423.
    PubMed         Abstract available


    Lasers Med Sci

  57. GUO W, He R, Hu Y, Gu K, et al
    Efficacy and safety of 5-aminolevulinic acid photodynamic therapy for cervical squamous intraepithelial lesion: a systematic review and meta-analysis.
    Lasers Med Sci. 2026;41:154.
    PubMed         Abstract available


    Mol Biol Rep

  58. GHOSH A, Bandyopadhyay A, Mukhopadhyay A
    Long non-coding RNAs: a new hope for the cervical cancer staging.
    Mol Biol Rep. 2026;53:1199.
    PubMed         Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  59. ZHU M, Liu X, Zhao S, Zhang X, et al
    [Interpretable machine learning models for preoperative precision prediction of perineural invasion in cervical cancer to support treatment decision: a multicenter retrospective study].
    Nan Fang Yi Ke Da Xue Xue Bao. 2026;46:1509-1519.
    PubMed         Abstract available


    Naunyn Schmiedebergs Arch Pharmacol

  60. AZMI MB, Wasi R, Sohail A, Asif U, et al
    Identification of miR-21-5p and miR-21-3p regulated hub genes and drug repurposing targets in cervical cancer: an integrative computational analysis.
    Naunyn Schmiedebergs Arch Pharmacol. 2026.
    PubMed         Abstract available


    Niger Med J

  61. ONYEMA CM, Nweke AN, Oliobi CW, Chimezie-Chilaka C, et al
    Determinants of Cervical Cancer Screening Uptake Among Antenatal Women in a Semi-Urban Hospital in Ebonyi State, Nigeria.
    Niger Med J. 2026;66:2264-2275.
    PubMed         Abstract available


    Oncol Lett

  62. ZHAO X, Wu J, Li L, Zhang H, et al
    A bioinformatics analysis of KIF transcriptomic subtyping reveals prognostic heterogeneity and differential therapeutic responses in cervical cancer.
    Oncol Lett. 2026;32:398.
    PubMed         Abstract available


    Oncol Rep

  63. MAKISE M, Uchimura R, Shiraishi A, Kuniyasu A, et al
    Stable overexpression of Nup88 enhances HeLa cell migration through independent regulation of Kif7 and Gli1.
    Oncol Rep. 2026;56:165.
    PubMed         Abstract available


    Pak J Pharm Sci

  64. GAO J, Liu Y, Sun G
    Effect of SJAMP on mTOR/p70S6K signaling pathway and invasion and migration ability of HeLa cells in cervical cancer.
    Pak J Pharm Sci. 2026;39:2960-2967.
    PubMed         Abstract available


    PLoS One

  65. TAFESE AM, Dirbaba B, Fentie M, Zeigler-Johnson C, et al
    Cervical cancer screening coverage and associated factors among women aged 25-59 in Eswatini: Insights from the 2021 Population-Based HIV Impact Assessment (PHIA).
    PLoS One. 2026;21:e0354508.
    PubMed         Abstract available

  66. ZENEBE S, Yeheyis T, Tadesse F, Deribe B, et al
    Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia.
    PLoS One. 2026;21:e0354372.
    PubMed         Abstract available


    Psychol Res Behav Manag

  67. CAI L, He M, Wang L, Xie Q, et al
    Prevalence and Associated Factors of Anxiety and Depression Among Family Caregivers of Patients with Cervical Cancer After Surgery: A Cross-Sectional Study.
    Psychol Res Behav Manag. 2026;19:600590.
    PubMed         Abstract available


    Radiother Oncol

  68. DATTA A, Biolatti LV, Reardon M, Bigos K, et al
    Hypoxia-associated gene signature for uterine cervical cancer.
    Radiother Oncol. 2026 Jul 23:111703. doi: 10.1016/j.radonc.2026.111703.
    PubMed         Abstract available


    Rev Assoc Med Bras (1992)

  69. BULBU R, Horasanli JE, Erdogan AC, Akkus F, et al
    Self-collected versus clinician-collected human papillomavirus samples.
    Rev Assoc Med Bras (1992). 2026;72:e20260122.
    PubMed         Abstract available


    Rev Esp Patol

  70. VILLARREAL RAMIREZ JC, Guaithero Rivas JE, Ramirez L, Pena Guillen J, et al
    Morphological differentiation of hyperchromatic crowded groups (HCG) in cervical cytology. Possible clinical significance.
    Rev Esp Patol. 2026;59:100883.
    PubMed         Abstract available


    Rev Esp Quimioter

  71. GONZALEZ CANTO J, Amparo Burgos-Isern M, Burgos-Teruel A
    Associations between high-risk human papillomavirus genotypes: evidence of HPV16 predominance as a monoinfection and its no stronger link with high-grade lesions.
    Rev Esp Quimioter. 2026;39:375-379.
    PubMed         Abstract available


    Sci Rep

  72. MEKONEN EG, Endalew HL, Bazezew AM, Zeleke GA, et al
    Screening for hypertension, diabetes, and cervical cancer in the democratic Republic of Congo: insights from a nationally representative survey.
    Sci Rep. 2026 Jul 20. doi: 10.1038/s41598-026-62712.
    PubMed         Abstract available


    Spectrochim Acta A Mol Biomol Spectrosc

  73. KAMANI T, Patel SK, Sharma Y, Al-Zahrani FA, et al
    A rapid detection of early-stage cervical cancer using nucleus and cytoplasm-based machine learning-driven refractive index surface plasmon resonance biosensor with ZnO-ag efficient materials.
    Spectrochim Acta A Mol Biomol Spectrosc. 2026;363.
    PubMed         Abstract available


    Urology

  74. HEBERT KJ
    Editorial Comment: "Treatment-Related Risk of Urologic Adverse Events in Cervical Cancer Survivors".
    Urology. 2026 Jul 20:S0090-4295(26)00449-8. doi: 10.1016/j.urology.2026.
    PubMed        


    Womens Health (Lond)

  75. KIBONIRE RA, Mphuthi DD, Twinomujuni M, Tumusiime A, et al
    Navigating realities: Client and provider perspectives on cervical cancer screening services in rural Uganda: A convergent mixed-methods study.
    Womens Health (Lond). 2026;22:17455057261471821.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum